Yokoyama, Utako http://orcid.org/0000-0003-1803-0155
Ichikawa, Yasuhiro
Minamisawa, Susumu
Ishikawa, Yoshihiro
Funding for this research was provided by:
Japan Society for the Promotion of Science (H1605358, 15H05761, 26670506, 24390200, 25670131)
National Institutes of Natural Sciences (22136009)
New Energy and Industrial Technology Development Organization (60890021)
NCVC (22-2-3)
Japan Agency for Medical Research and Development (66890005, 66890011, 66890001, 66890023)
MEXT fund for Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program in the Project for Developing Innovation Systems (15638648)
the Vehicle Racing Commemorative Foundation (N/A, N/A)
Article History
Received: 27 June 2016
Accepted: 6 December 2016
First Online: 20 December 2016
Compliance with ethical standards
:
: Utako Yokoyama has received a speaker honorarium from Eisai Co., Ltd., Japan Blood Products Organization and Mitsubishi Tanabe Pharma Corporation. Yasuhiro Ichikawa, Susumu Minamisawa, and Yoshihiro Ishikawa declare that they have no conflict of interest.
: Human CoA tissue was obtained from Yokohama City University Hospital at the time of corrective operations. The study was approved by the human subject committees at Yokohama City University (B100107034). A sample was obtained after receiving written informed parental consent.
: This study has been supported in part by JSPS (UY, H1605358, 15H05761, 26670506; SM, 26293249, 26670096, 23136516; YI, 24390200, 25670131), MEXT (YI, 22136009), NEDO (YI, 60890021), NCVC (YI, 22-2-3), AMED (YI, 66890005, 66890011, 66890001, 66890023), the Vehicle Racing Commemorative Foundation (UY and SM), and the MEXT fund for Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program in the Project for Developing Innovation Systems (UY, 15638648).
Free to read: This content has been made available to all.